Are you or someone you know living with epilepsy? If so, you understand the challenges and limitations that come with this neurological disorder. Epilepsy can dramatically impact a person's quality of life, making daily activities difficult to manage and imposing restrictions on their personal freedom. However, there is new hope for those affected by epilepsy: perampanel. In this blog post, we'll explore how perampanel is changing lives and providing much-needed relief for people living with epilepsy.
Perampanel is a new anti-epileptic drug that was approved by the FDA in 2012. It is the first in a new class of drugs called selective aminergic receptor antagonists. Perampanel works by binding to and inhibiting ion channels in the brain that are involved in seizure activity.
Perampanel has been shown to be effective in reducing seizure frequency in both adults and children with epilepsy. In clinical trials, perampanel was associated with a significant reduction in seizure frequency compared to placebo. In addition, perampanel was well-tolerated, with the most common side effects being dizziness, headache, and fatigue.
Perampanel is currently approved for use as adjunctive therapy for seizures associated with Lennox-Gastaut syndrome (LGS) or idiopathic generalized epilepsy (IGE). However, it is being investigated for use in other types of epilepsy as well.
Perampanel is a relatively new anti-epileptic medication that was first approved by the FDA in 2012. It works by inhibiting glutamate, a neurotransmitter that is linked to seizure activity. In clinical trials, perampanel has been shown to be effective in reducing seizure frequency in both adults and children with epilepsy.
Perampanel is typically taken once daily, at night. The most common side effects include dizziness, headache, and fatigue. More serious side effects include changes in mood and behavior, as well as suicidal thoughts or actions.
Side effects of perampanel can include dizziness, headaches, sleepiness, irritability, aggression, and mood swings. More serious side effects can include psychosis, depression, and suicidal thoughts.
When it comes to epilepsy, there are many different types of seizures that can occur. And while there are various medications available to help control them, some people still struggle to find one that works for them. But a newer medication called perampanel is changing lives by providing better seizure control with fewer side effects.
Epilepsy is a disorder that causes recurrent seizures. There are many different types of seizures, and they can vary in severity. Some people with epilepsy only have occasional mild seizures, while others have frequent or severe ones that can be disabling. There is no cure for epilepsy, but medications can help control seizures.
Perampanel is a new type of anti-seizure medication that was approved by the FDA in 2012. It works by blocking receptors for the neurotransmitter glutamate. Glutamate is involved in excitatory neurotransmission, and overexcitation of neurons is thought to play a role in seizure activity. Perampanel has been shown to be effective in reducing seizure frequency and severity in people with various types of epilepsy. It is typically well-tolerated, with the most common side effects being dizziness, sleepiness, headache, and nausea.
Perampanel is changing lives by providing better seizure control for many people with epilepsy. It has been shown to be effective against various types of seizures and is generally well-tolerated. If you or someone you know has epilepsy and is struggling to find an effective
Perampanel has had a tremendous impact on the lives of people living with epilepsy. It is a safe and effective treatment that can significantly reduce the frequency and severity of seizures in those with partial-onset or primary generalized tonic-clonic seizures, as well as reduce the risk of developing seizure clusters. While there are still many unanswered questions regarding its long-term effects, it is clear that perampanel has revolutionized epilepsy treatment and changed countless lives for the better.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
2.
How artificial intelligence could significantly improve the prognosis for cancer patients.
3.
Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.
4.
Overdosing on Chemotherapy: A Single Gene Test Could Prevent Hundreds of Deaths Annually.
5.
Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.
1.
Understanding Neutrophilia: Causes, Symptoms, and Treatment Options
2.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
3.
A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology
4.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
5.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation